EUVIMEDEUVIMED entdecken
Crossref

Mesenchymal stem cells improve cardiac function in diabetic rats by reducing cardiac injury biomarkers and downregulating JAK/STAT/iNOS and iNOS/Apoptosis signaling pathways

Thoraya Mohamed Elhassan A-Elgadir, Ayed A Shati, Saif Aboud Alqahtani, Hasnaa A Ebrahim, Hailah M Almohaimeed, Asmaa M ShamsEldeeen, Mohamed A Haidara, Samaa S Kamar, Amal F Dawood, Mahmoud H El-Bidawy

Molecular and Cellular Endocrinology · 2024-09 · 591 · 112280

DOI: 10.1016/j.mce.2024.112280 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2024-09. Verfasst von Thoraya Mohamed Elhassan A-Elgadir und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, College of Medicine, King Khalid University, Abha, Saudi Arabia. Hauptthemen laut MEDLINE: Apoptosis, Biomarkers, Diabetes Mellitus, Experimental, Mesenchymal Stem Cell Transplantation. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: Princess Noura Bint AbdulRahman University, Deanship of Scientific Research, Princess Nourah Bint Abdulrahman University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular complications are prevalent manifestations of type 2 diabetes mellitus (T2DM) and are usually the main cause of death. This study aims to show the underlying mechanisms of the potential therapeutic effect of mesenchymal stem cells (MSCs) on diabetic cardiac dysfunction. Twenty-four male Wistar rats were randomly assigned to one of three groups The control group received standard laboratory chow, and the groups with T2DM received a single dose of 45 mg/kg body weight of streptozotocin (STZ) after 3 weeks of pretreatment with a high-fat diet (HFD). Eight weeks after the diagnosis of T2DM, rats were divided into two groups: the T2DM model group and the T2DM + MSCs group. BM-MSCs were administered systemically at 2 × 106 cells/rat doses. A Significant amelioration in Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) and dyslipidemia was noted 2 weeks post-administration of MSCs. Administration of MSCs improved dyslipidemia, the altered cardiac injury biomarkers (p ≤ 0.0001), downregulated Janus kinase 2/signal transducer and activator of transcription 3(JAK2/STAT3)/inducible Nitric oxide synthase (iNOS) and iNOS/Apoptosis signaling pathways. This was associated with improved cardiac dysfunction (impaired left ventricular performance and decreased contractility index). Our results show that MSCs ameliorate cardiac dysfunction associated with diabetic cardiomyopathy by lowering dyslipidemia and insulin resistance, inhibiting oxidative stress, and inflammation, downregulating JAK2/STAT3/iNOS and iNOS/Apoptosis signaling pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisBiomarkersDiabetes Mellitus, ExperimentalMesenchymal Stem Cell TransplantationMesenchymal Stem CellsSignal TransductionAnimalsMaleRatsDiabetes Mellitus, Type 2Down-RegulationHeart InjuriesJanus Kinase 2Janus KinasesNitric Oxide Synthase Type IIRats, WistarSTAT Transcription FactorsSTAT3 Transcription Factor

Stichwörter der Autor:innen

ApoptosisCardiomyopathyJAK2/STAT3/ iNOS signaling pathwayMSCsT2DM

Substanzen

BiomarkersJanus Kinase 2Janus KinasesNitric Oxide Synthase Type IINos2 protein, ratSTAT Transcription FactorsStat3 protein, ratSTAT3 Transcription Factor

Autor:innen und Institutionen

  • Department of Clinical Biochemistry, College of Medicine, King Khalid University, Abha, Saudi Arabia.
  • Department of Child Health, College of Medicine, King Khalid University, Abha, Saudi Arabia.
  • Department of Internal Medicine, College of Medicine, King Khalid University, Abha, Saudi Arabia.
  • Department of Basic Medical Sciences, College of Medicine, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh, 11671, Saudi Arabia.
  • Department of Physiology, Kasr Al-Aini Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Department of Histology, Kasr Al-Aini Faculty of Medicine, Cairo University, Cairo, Egypt; Department of Histology, Armed Forces College of Medicine.

Förderung

  • Princess Noura Bint AbdulRahman University
  • Deanship of Scientific Research, Princess Nourah Bint Abdulrahman University

Zitieren

APA

A-Elgadir, T. M. E., Shati, A. A., Alqahtani, S. A., Ebrahim, H. A., Almohaimeed, H. M., ShamsEldeeen, A. M., Haidara, M. A., Kamar, S. S., Dawood, A. F., & El-Bidawy, M. H. (2024). Mesenchymal stem cells improve cardiac function in diabetic rats by reducing cardiac injury biomarkers and downregulating JAK/STAT/iNOS and iNOS/Apoptosis signaling pathways. Molecular and Cellular Endocrinology, 591, 112280. https://doi.org/10.1016/j.mce.2024.112280

Vancouver

A-Elgadir TME, Shati AA, Alqahtani SA, Ebrahim HA, Almohaimeed HM, ShamsEldeeen AM, et al. Mesenchymal stem cells improve cardiac function in diabetic rats by reducing cardiac injury biomarkers and downregulating JAK/STAT/iNOS and iNOS/Apoptosis signaling pathways. Molecular and Cellular Endocrinology. 2024;591:112280. doi:10.1016/j.mce.2024.112280

BibTeX
@article{AElgadir2024,
  author = {A-Elgadir, Thoraya Mohamed Elhassan and Shati, Ayed A and Alqahtani, Saif Aboud and Ebrahim, Hasnaa A and Almohaimeed, Hailah M and ShamsEldeeen, Asmaa M and Haidara, Mohamed A and Kamar, Samaa S and Dawood, Amal F and El-Bidawy, Mahmoud H},
  title = {Mesenchymal stem cells improve cardiac function in diabetic rats by reducing cardiac injury biomarkers and downregulating JAK/STAT/iNOS and iNOS/Apoptosis signaling pathways},
  journal = {Molecular and Cellular Endocrinology},
  year = {2024},
  volume = {591},
  pages = {112280},
  doi = {10.1016/j.mce.2024.112280}
}
Kostenlos starten →